Trib2 Confers Resistance to Anti-Cancer Therapy by Activating the Serine/Threonine Protein Kinase Akt (Retraction of Vol 8, Art No 14687, 2017)
AuthID
P-00Y-WVM
P-00Y-WVM
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service